Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ), and ResearchDx DBA PacificDx proudly announce ProMarkerD, the groundbreaking predictive test for diabetic kidney disease. This innovative test empowers clinicians and patients by enabling early intervention to slow or prevent kidney function decline.

Press Release

@PromarkerD

Leave a Reply

Your email address will not be published. Required fields are marked *